Saliva test
- August 20, 2020
- Posted by: OptimizeIAS Team
- Category: DPN Topics
No Comments
Subject: Science and tech
Context:
US Food and Drug Administration (FDA) approved a new method of testing for Covid-19 by processing saliva samples
Concept:
- The inexpensive test called Saliva Direct has high sensitivity and can detect the virus even when the number of virus copies in the saliva sample is as low as 6-12 copies per microlitre.
- Collecting and testing saliva samples involves three steps collecting saliva without preservative buffers, proteinase K treatment and heat inactivation, and dualplex RT-qPCR virus detection.
Significance:
- The new saliva test would increase efficiency and avoid shortage of crucial test components such as reagents.
- The new test makes sample collection non-invasive and reduces the need for trained healthcare workers to collect the samples, reducing the risk of infection during collection.
- In contrast, tests using nasopharyngeal swabs lead to false negative results due to errors at the time of sample collection.
Testing methods:
- Broadly, there are two types of tests for Covid-19.
- One type, which detects the virus itself, includes the RT-PCR test and the antigen test.
- The second is the serological test, which looks for antibodies developed by the body against the virus. This determines if a person has been exposed to the infection, and is used for surveillance of infection in a community.
- In the first category of tests, nose and throat swabs are used as the sampling technique .
- After the swab is removed, the sample is placed in a viral transport media and is preserved for analysis.
- Researchers have developed the saliva test as a low-cost alternative; the suspected patient has only to spit into a sterile tube and the sample is then sent it to the laboratory.